1. Home
  2. SURG vs RNXT Comparison

SURG vs RNXT Comparison

Compare SURG & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$1.63

Market Cap

47.6M

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.97

Market Cap

36.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
RNXT
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
36.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SURG
RNXT
Price
$1.63
$0.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.50
$7.75
AVG Volume (30 Days)
116.0K
195.2K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,372,555.00
$928,000.00
Revenue This Year
$7.13
$2,795.35
Revenue Next Year
$122.51
$272.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$0.70
52 Week High
$3.47
$1.69

Technical Indicators

Market Signals
Indicator
SURG
RNXT
Relative Strength Index (RSI) 38.46 51.67
Support Level $1.61 $0.83
Resistance Level $1.90 $1.00
Average True Range (ATR) 0.17 0.06
MACD 0.03 0.01
Stochastic Oscillator 46.15 71.95

Price Performance

Historical Comparison
SURG
RNXT

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: